Free radical reactions are strongly implicated in the pathogenesis of many diseases.' Pro-oxidative free radicals can potentially be chemically neutralized by naturally occurring antioxidants in biological fluids. A number of components present in serum have been shown to possess chain breaking antioxidant capacity including vitamins C and E, bilirubin, urate and protein thiols in aqueous or organic solution in vitro.i:" Measurement of total antioxidant capacity (T AC) of biological fluids is believed to be a useful measure of the ability of antioxidants present in the fluids to protect against oxidative damage to membranes and other cellular components. The large variety of components of serum with potential antioxidant capacity has led to the development and widespread use of assays which claim to measure TAC, thereby providing a clinically useful global measure. A number of methods have been developed over the past few years which allow the rapid and simple measurement of TAC of serum.s" As part of a reference value study on serum biochemistry being conducted concurrently in the laboratory we undertook an investigation to measure the total antioxidant capacity of serum samples. The 41 volunteers in the study were normal healthy non-smokers aged 19-59 [mean 32·9 (SD lOA)] who had not taken any medication or alcohol in the 5 days prior to blood collection. Whole blood 6 mL was collected between 0800 and 1000 h into SST Vacutainer tubes for biochemical investigations. Measurement of urate, total bilirubin, and total protein were carried out on a Technicon AXON analyser. The enhanced chemiluminescent Correspondence to: Dr Michael Ryan, Clinical Chemistry Laboratory, Antrim Hospital, Antrim BT41 2RL, Ireland, UK.
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(ECL) method.I the total radical-trapping antioxidant parameter (TRAP) assay' and the 2, 2'-azino-bis-(3-ethylbenzo-thiaoline-6-sulphonic acid) (ABTS) assay" are the three main methods that have been utilized to measure the antioxidant capacity of individual compounds and crude extracts such as serum. We chose the ECL method for this study as it has been shown to be more rapid and less prone to external factors.i-' A standard curve of antioxidant capacity was produced using Trolox (Aldrich Chemical Co Ltd, Dorset, UK), a water soluble vitamin E analogue. ECL signal reagent was obtained in kit form from Amersham International Pic (Buckinghamshire, UK). Light output was measured using a BioOrbit 1250 Luminometer. For the antioxidant measurement serum was immediately aspirated and stored at -70°C until analysis (within I month). Preliminary experiments demonstrated that this procedure had no effect on TAC when compared with serum measured immediately.
The TAC of the serums assayed ranged from 201--6221lmol/L [mean 3821lmol/L (SD 79)]. Comparison with the 30 other biochemical parameters measured revealed that the serum T AC strongly correlated with serum urate concentrations (r = 0·93 by least squares regression method, P<O·OOOI by Student's t-test) (see Fig. I ). None of the other analytes measured had significant correlations with the TAC. This suggested that urate accounted for almost all the antioxidant capacity of the serum samples. In order to definitively prove that it was the urate that was primarily responsible for the antioxidant capacity we depleted serum of urate using uricase. Serum was completely depleted of urate by incubation with 8 mU uricase (Dupont, URCA kit) per 0·05 mL serum for 50 min at 25°C. The incubation resulted in a complete abolition of antioxidant capacity as measured by ECL. (The small amount of hydrogen peroxide formed during the conversion of the urate to allantoin did not affect the antioxidant status of the serum samples). This result indicated that urate was the only antioxidant that appears to be measured by the ECL assay. Any residual antioxidant capacity accounted for by other serum components (such as vitamins C and E, bilirubin and protein thiols) in healthy individuals must therefore be below the detection limits in the ECL assay. As a result of our findings we have reviewed the literature on other groups' work on this area. Unfortunately, none of these studies appear to have determined correlation coefficients for individual serum components and TAC. Interestingly, however, the TRAP assay correlates quite well with the ECL assay (r=0'76)2 and Goode and co-workers found that antioxidant capacity results from plasma samples measured using the ECL, TRAP and ABTS methods were not significantly different, although no correlation coefficients were quoted.' It would, therefore, be pertinent to determine if these and other tests used to determine TAC in serum correlate with serum urate.
Despite its role as a potent endogenous antioxidant urate has not received as much attention as dietary antioxidants in medical literature. Interestingly however the relatively high levels of urate in humans compared to non-primates has led a number of researchers to postulate that urate is the most important small molecule antioxidant and radical scavenger in humans and therefore has a crucial physiological role", Unfortunately, to our knowledge there has been no clinical study of the benefits of urate in diseases in which free radicals are thought to be involved.
CONCLUSIONS
We conclude that the antioxidant activity of serum from ostensibly healthy individuals quantitated using the ECL test is almost completely accounted for by urate. The increasing interest in antioxidants and the desire for some global index of antioxidant capacity coupled with the apparent ease with which TAC can be measured in serum using a variety of novel assays may lead to uncritical acceptance of these new technologies. Clearly further work is necessary to address this important issue if methods which claim they measure TAC are to be used in future.
